The FDA approved Bildyos and Bilprevda are providing new options comparable to Prolia and Xgeva for osteoporosis, cancer-related bone disease, and other skeletal conditions.
Researchers found that an at-home self-collection device for HPV testing demonstrated high accuracy and safety, matching clinician-collected results for cervical cancer screening.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
The incidence of late-stage, invasive breast cancer has risen significantly across all age groups and ethnicities in the U.S. from 2004 to 2021, emphasizing the critical need for enhanced breast cancer screening and early detection.
A recent study found that current transvaginal ultrasonography triage strategies may not be useful for accurately diagnosing endometrial cancer among Black patients at risk for the malignancy.
New research from the Mayo Clinic shows promising results for a noninvasive methylated DNA marker panel that could reduce the number of unnecessary and painful biopsies in patients with abnormal uterine bleeding.